Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Elaborates On Celebrex Safety Theory: Molecule Is “Unique”

Executive Summary

Celebrex can be differentiated from other COX-2 inhibitors based on relative rates of association with hypertensive cell retention, Pfizer Worldwide Development President Joe Feczko told analysts Nov. 30 in Groton, Conn
Advertisement

Related Content

Vioxx Cardiovascular Risk Is Unique To Molecule, Pfizer And Novartis Tell FDA
Vioxx Cardiovascular Risk Is Unique To Molecule, Pfizer And Novartis Tell FDA
Bextra Meta-Analysis Affirms Safety Profile, Pfizer Tells Physicians
Bextra Meta-Analysis Affirms Safety Profile, Pfizer Tells Physicians
Bextra Meta-Analysis Affirms Safety Profile, Pfizer Tells Physicians
COX-2 Advisory Committee May Decide Fate of Pfizer’s Bextra
Pfizer Goes On Offense With Celebrex: TV Ads, Study Proposal Stress Safety
Pfizer Goes On Offense With Celebrex: TV Ads, Study Proposal Stress Safety
Pharmacia parecoxib

Topics

Advertisement
UsernamePublicRestriction

Register

PS045070

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel